Article information
Resumen
La fibrilación auricular (FA) es la arritmia cardíaca más frecuente y responsable de un porcentaje importante de ictus isquémicos; como tal tiene su impacto en la gravedad del ictus y en la morbimortalidad de éste. Su importancia como factor etiológico del ictus aumenta con la edad, y además estamos asistiendo a un aumento de su detección en las últimas décadas. La presencia de FA condiciona una mayor intensidad del déficit neurológico inicial, una estancia hospitalaria más prolongada y una peor evolución funcional con mayor discapacidad y menor probabilidad de poder volver al domicilio habitual; además, es un factor de riesgo independiente de mortalidad, especialmente en mujeres y en población de edad avanzada. Todo esto conlleva que los pacientes con ictus con FA presenten un mayor impacto socioeconómico.
Palabras clave:
Ictus
Fibrilación auricular
Impacto
Abstract
Atrial fibrillation (AF) is the most frequent heart arrhythmia and causes a substantial proportion of ischemic strokes. AF has a marked impact on stroke severity, as well as on morbidity and mortality in these patients. The importance of AF as an etiologic factor of stroke increases in the elderly and in the last few years its detection has increased. The presence of AF leads to more severe initial neurological involvement, longer hospitalization, greater disability and a lower probability of discharge to home. In addition, AF is an independent risk factor for mortality, especially in women and the elderly. All these factors lead to a higher social and economic impact among stroke patients with AF.
Keywords:
Stroke
Atrial fibrillation
Impact
Full text is only aviable in PDF
Bibliografía
[1.]
S. Levy.
Epidemiology and classification of atrial fibrillation.
J Cardiovasc Electrophysiol, 98 (1998), pp. S78-S82
[2.]
A.S. Go, E.M. Hylek, K. Phillips, Y. Chang, L.E. Henault, J.V. Selby, et al.
Prevalence of diagnosed atrial fibrillation in adults national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study.
JAMA, 285 (2001), pp. 2370-2375
[3.]
B. Brüggenjürgen, K. Rossnagel, S. Roll, F.L. Andersson, D. Selim, J. Müller-Nordhorn, et al.
The impact of atrial fibrillation on the cost of stroke: The Berlin Acute Stroke Study.
Value Health, 10 (2007), pp. 137-143
[4.]
K.M. Ryder, E.J. Benjamin.
Epidemiology and significance of atrial fibrillation.
Am J Cardiology, 84 (1999), pp. 131R-R138
[5.]
K. Lakshminarayan, C.A. Solid, A.L. Collins, D.C. Anderson, C.A. Herzog.
Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002).
Stroke, 37 (2006), pp. 1969-1974
[6.]
H.J. Lin, P.A. Wolf, M. Kelly-Hayes, A.S. Meiser, C.S. Kase, E.J. Benjamin, et al.
Stroke severity in atrial fibrillation. The Framingham Study.
Stroke, 27 (1996), pp. 1760-1764
[7.]
M.D. Ezekowitz, P. Netrebo.
Anticoagulation in management of atrial fibrillation.
Curr Opin Cardiol, 18 (2003), pp. 26-31
[8.]
S. Stewart, C.L. Hart, D.J. Hole, J.J. McMurray.
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.
Am J Med, 113 (2002), pp. 359-364
[9.]
R. De Caterina, S.J. Connolly, J. Pogue, S. Chrolavicius, A. Budaj, J. Morais, et al.
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W.
Eur Heart J, (2010),
[10.]
Guía de Práctica Clínica sobre la Prevención Primaria y Secundaria del Ictus. Grupo de trabajo de la guía de prevención del ictus. Centro Cochrane Iberoamericano, coordinador. Guía de práctica clínica sobre la prevención primaria y secundaria del ictus. Madrid: Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Consumo. Agència d’Avaluació de Tecnologia i Recerca Mèdiques. 2008. Guía de práctica clínica: AATRM Nª 2006/15.
[11.]
P.A. Wolf, R.B. D’Agostino, M.A. O’Neal, P. Sytkowski, C.S. Kase, A.J. Belanger, et al.
Secular trends in stroke incidence and mortality. The Framingham Study.
Stroke, 23 (1992), pp. 1551-1555
[12.]
T.S. Tsang, G.W. Petty, M.E. Barnes, W.M. O’Fallon, K.R. Bailey, D.O. Wiebers, et al.
The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades.
J Am Coll Cardiol, 42 (2003), pp. 93-100
[13.]
R.G. Hart, D.G. Sherman, J.D. Easton, J.A. Cairns.
Prevention of stroke in patients with non valvular atrial fibrillation.
Neurology, 51 (1998), pp. 674-681
[14.]
T.J. Wang, J.M. Massaro, D. Levy, R.S. Vasan, P.A. Wolf, R.B. D’Agostino, et al.
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. The Framingham Heart Study.
JAMA, 290 (2003), pp. 1049-1056
[15.]
C. Bernick, L. Kuller, C. Dulberg, W.T. Longstreth Jr., T. Manolio, N. Beauchamp, et al.
Silent MRI infarcts and the risk of stroke. The Cardiovascular Health Study.
Neurology, 57 (2001), pp. 1222-1229
[16.]
W.B. Kannel, P.A. Wolf, E.J. Benjamin, D. Levy.
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.
Am J Cardiol, 82 (1998), pp. 2N-9N
[17.]
M.D. Ezekowitz, R.H. Falk.
The increasing need of anticoagulation therapy to prevent stroke in patients with atrial fibrillation.
Mayo Clin Proc, 79 (2004), pp. 904-913
[18.]
H.S. Jorgensen, H. Nakayama, J. Reith, H.O. Raaschou, T.S. Olsen.
Acute stroke with atrial fibrillation. The Copenhagen Stroke Study.
Stroke, 27 (1996), pp. 1765-1769
[19.]
E. Palomeras Soler, J. Roquer González.
Ictus y fibrilación auricular.
Neurología, 15 (2000), pp. 51-57
[20.]
J. Roquer, A. Rodríguez Campello, M. Gomis.
Sex differences in first-ever acute stroke.
Stroke, 34 (2003), pp. 1581-1585
[21.]
K. Kimura, Y. Iguchi, S. Yamashita, K. Shibazaki, K. Kobayashi, T. Inoue.
Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
J Neurol Sci, 267 (2008), pp. 57-61
[22.]
K. Kimura, Y. Iguchi, K. Shibazaki, T. Iwanaga, S. Yamashita, J. Aoki.
IV t-PA therapy in acute stroke patients with atrial fibrillation.
J Neurol Sci, 276 (2009), pp. 6-8
[23.]
M. Kaarisalo, P. Immonen-Raiha, R. Marttila, V. Salomaa, E. Kaarsalo, K. Salmi.
Atrial fibrillation and stroke mortality and causes of death after the first acute ischemic stroke.
Stroke, 28 (1997), pp. 311-315
[24.]
R. Saxena, S. Lewis, E. Berge, P.A.G. Sandercock, P.J. Koudstaal.
Risk of early death and recurrent stroke and effect of heparin in 3 169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial.
Stroke, 32 (2001), pp. 2333-2337
[25.]
D.A. Dulli, H. Stanko, R.L. Levine.
Atrial fibrillation is associated with severe acute ischemic stroke.
Neuroepidemiol, 22 (2003), pp. 118-123
[26.]
K. Kimura, K. Minematsu, T. Yamaguchi, Japan Multicenter Stroke Investigators’ Collaboration (J-MUSIC).
Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke.
J Neurol Neurosurg Psychiatry, 76 (2005), pp. 679-683
[27.]
S.L. Kopecky, B.J. Gersh, M.D. McGoon, C.P. Chu, D.M. Ilstrup, J.H. Chesebro, et al.
Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk.
Arch Intern Med, 159 (1999), pp. 1118-1122
[28.]
L. Candelise, G. Pinardi, A. Morabito.
Mortality in acute stroke with atrial fibrillation. The Italian Acute Stroke Study Group.
Stroke, 22 (1991), pp. 169-174
[29.]
J. Roquer, A. Rodríguez-Campello, E. Cuadrado-Godia, R.M. Vivanco- Hidalgo, J. Jiménez-Conde, X. Perich, et al.
Acute brain MRIDWI patterns and stroke recurrence after mild-moderate stroke.
J Neurol, 257 (2010), pp. 947-953
[30.]
Roquer González J, Álvarez-Sabín J. Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología. ¿Es el ictus cardioembólico la gran amenaza del anciano? El ictus en la persona mayor. 2009;31–45.
[31.]
P. Appelros, I. Nydeik, M. Viitanen.
Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year.
Stroke, 34 (2003), pp. 122-126
[32.]
M.M. Kaarisalo, P. Immonen-Ralha, R.J. Marttila, A. Lehtonen, V. Salomaa, C. Santi, et al.
Atrial fibrillation in older stroke patients: association with recurrence and mortality after first ischemic stroke.
J Am Geriatr Soc, 45 (1997), pp. 1297-1301
[33.]
J. Roquer, A. Rodríguez Campello, A. Ois, M. Gomis, J.E. Martínez-Rodríguez, E. Munteis, et al.
Comparison of the impact of atrial fibrillation on the risk of early death after stroke in women versus men.
J Neurol, 253 (2006), pp. 1484-1489
[34.]
M. Awadh, N. Mac Dougall, C. Santosh, E. Teasdale, T. Baird, K.W. Muir.
Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke. Incidente and association with atrial fibrillation.
Stroke, 41 (2010), pp. 1990-1995
[35.]
O. Ghatnekar, E.L. Glader.
The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidende data from 2001.
Value Health, 11 (2008), pp. 862-868
[36.]
P. Navarrete-Navarro, R. Rivera-Fernández, M.T. López-Mutuberría, I. Galindo, F. Murillo, et al.
(Evascan Project, Andalusia Spain). Outcome prediction in terms of functional disability and mortality at 1 year among ICU-admitted severe stroke patients: a prospective epidemiological study in the south of the European Union.
Intensive Care Med, 29 (2003), pp. 1327-1344
[37.]
J. Mar, J.M. Beguiritain, A. Arrazola.
Cost-effectiveness of thombolisis for Stroke.
Cerebrovasc Dis, 20 (2005), pp. 193-200
[38.]
Jorgensen N, Oliva J, López Batisda J, Serrano P. Análisis de los costes sociales de los accidentes cerebrovasculares en la Comunidad Canaria. Mimeo, 2007.
[39.]
Oliva J, Hidalgo A, González A, Aranda I. Cuidados informales prestados a personas supervivientes a un ACV en España: una perspectiva económica. Comunicación oral. XVI Congreso Nacional de la SEAUS, 2011.
[40.]
A. Hidalgo, J. Oliva, A. González, I. Aranda.
Cuidados informales asociados a la limitación de la autonomía en supervivientes a accidentes cerebrovasculares.
Gac Sanit., 1 (2011), pp. 1-2
[41.]
Solà-Morales O, Elorza JM. Coagulómetros portátiles. Revisión de la evidencia científica y evaluación económica de su uso en el autocontrol del tratamiento anticoagulante oral. IN06/2003. AATRM Generalitat de Catalunya. Julio de 2003 [en línea]. <www.gencat.cat/salut/depsan/units/aatrm/pdf/in0306es.pdf>
[42.]
J. Álvarez-Sabín, J. Mar, J. Oliva, J. Masjuan, V. Becerra, C. Aleix, et al.
Costes socioeconómicos del ictus en España: Estudio “CONOCES”.
Gac Sanit, 1 (2011), pp. 1-2
[43.]
J. Álvarez-Sabín, M. Yébenes Cortés, J. Mar Medina, J. Oliva Moreno, C. Aleix Ferrer, N. González-Rojas, et al.
Características clínicas y demográficas de los pacientes con ictus, con y sin fibrilación auricular. Estudio CONOCES, costes socioeconómicos del ictus en España.
Neurología, (2011), pp. 120-290
[44.]
Álvarez-Sabín J, Masjuan J, Yébenes M, Mar J, Oliva J, González Rojas N, et al. Are hospital costs for stroke underestimated in Spain? Value in Health Volume 14, Issue 7. 2011 A 2 3 3 - A 5 1 0. Disponible en: http://www.ispor.org/publications/value/JVAL_147_FINAL.pdf
Copyright © 2012. Sociedad Española de Neurología
